Search Orphan Drug Designations and Approvals
-
| Generic Name: | opaganib |
|---|---|
| Date Designated: | 10/19/2024 |
| Orphan Designation: | treatment of neuroblastoma |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Apogee Biotechnology Corporation 1214 Research Blvd, Suite 2015 Hummelstown, Pennsylvania 17036 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







